Novavax, a Maryland-based company that received $1.75 billion from the United States government to develop a protein-based Covid-19 vaccine, announced Monday it had won emergency authorization for its vaccine in Indonesia.

After months of production delays, this is the first authorization for Novavax and its manufacturing partner, the Serum Institute of India. They have also applied for clearance in India and the Philippines, and Novavax has applied on its own to other countries, including Britain and Canada.

Continue reading “The Novavax vaccine, backed by Operation Warp Speed, has won its first authorization — in Indonesia.” →

The National Institutes of Health said on Wednesday that a nonprofit group under fire from some congressional Republicans for its research collaborations in China had failed to promptly report findings from studies on how well bat coronaviruses grow in mice.

In a letter to Representative James Comer, Republican of Kentucky, the N.I.H. said that the group, EcoHealth Alliance, had five days to submit all unpublished data from work conducted under a multiyear grant it was given in 2014 for the research. The organization’s grant was canceled in 2020 under President Donald J. Trump’s administration during his feud with China over the origins of the coronavirus.

Continue reading “Bat Research Group Failed to Submit Virus Studies Promptly, N.I.H. Says” →

The Food and Drug Administration seems likely to allow Americans to switch vaccines when choosing a Covid-19 booster shot. That authorization, which could come this week, is the latest development in a long-running debate over whether a mix-and-match strategy helps protect people from the coronavirus.

Here are answers to some common questions about mixing and matching booster shots.

Continue reading “Mix-and-Match Covid Boosters: Why They Just Might Work” →

When an advisory panel to federal regulators endorsed boosters for Johnson & Johnson’s one-dose Covid-19 vaccine on Friday, the scientists on the committee discussed a question many people are asking: Is it a good idea to mix and match vaccines?

The question came up after the panel heard a presentation about a study showing that the mix-and-match approach gives patients who received the Johnson & Johnson vaccine a stronger antibody response.

Continue reading “An F.D.A. panel explores mixing and matching vaccine doses.” →

WASHINGTON — A key federal advisory committee voted unanimously Friday to recommend Johnson & Johnson booster shots, most likely clearing the way for all 15 million people who got the company’s one-dose coronavirus vaccine to receive a second shot.

If the Food and Drug Administration and the Centers for Disease Control and Prevention accept the recommendation, as expected, boosters could be offered by late next week. But many committee members made clear that they believed Johnson & Johnson recipients might benefit from the option of a booster of the Pfizer-BioNTech or Moderna vaccine, something a top F.D.A. official said the agency was considering.

Continue reading “F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots” →